BioStem Technologies Applies for Uplisting to the OTCQX Market

BioStem Technologies (OTC PINK: BSEM) a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine, announced today that it has completed its application to uplist on OTCQX, a higher tier Over The Counter market overseen by OTCMarkets.

As quoted in the press release:

Henry Van Vurst, CEO of BioStem Technologies, stated, “We’ve been aggressively preparing for this uplist for months now, meeting all financial reporting obligations and completing the submission of all application documents required by OTCMarkets, Inc. We expect the uplist to add value for our shareholders by enabling our stock to be quoted and traded by a much wider range of brokerages, particularly retail brokers.”

Click here to read the full press release.